HERZELIYA, Israel, November 30, 2011 /PRNewswire/ –
MinoGuard develops drugs to treat mental health diseases. MinoGuard’s lead drug for the treatment of schizophrenia patients is intended to improve the efficacy of existing treatments and minimize their side effects.
MinoGuard has…
Popularity: 1% [?]

